Description :
‘ In-vitro diagnostics ( IVD ) quality controls ( QC )’ are liquid or lyophilized samples or materials , which are used by laboratories to check the testing process to ensure reliability and accuracy of testing results . The regulatory bodies and accredited bodies insist on using quality controls for every test performed in laboratories . However , laboratories use quality controls for testing products when reagent batches are changed , analyzers / instruments are serviced , or test results seem incorrect .
Check the DISCOUNT on this report @ http :// www . orbisresearch . com / contacts / discount / 216084 .
The global IVD quality control products market was valued at $ 823 million in 2015 , and is expected to reach $ 1,052 million by 2022 , registering a CAGR of 3.5 % from 2016 to 2022 . The market is driven by factors such as increase in adoption of third party quality control products , upsurge in the number of laboratories and diagnostic centers worldwide , and stringent norms for using controls . However , poor reimbursement framework and lack of regulations on the use of controls in the emerging economies are projected to hamper the market growth during the analysis period .
The global IVD quality controls products market is segmented based on product type into quality controls , IVD quality control data management software , and IVD quality assurance services . In 2015 , the quality controls segment accounted for the largest share in the global market , and is estimated to grow at the fastest CAGR of 3.7 % during the analysis period . The market growth is attributed to upsurge in demand for third-party quality control products and services .
The IVD quality controls market is segmented based on application into clinical chemistry , immunochemistry , hematology , molecular diagnostics , coagulation , microbiology , and others . The molecular biology diagnostics segment is estimated to grow at the fastest CAGR of 5.3 % during the analysis period . The end users of the market are hospitals , clinical laboratories , research & academic institutes , and others . The hospitals segment held the largest share in the global IVD quality control products market in 2015 .
Based on manufacturer type , the market is segment into instrument manufacturer controls and independent manufacturer controls including third party controls and instrument specific controls . The independent manufacturer controls segment dominated the market in 2015 , and is estimated to grow at the fastest CAGR during the forecast period , owing to the increase in demand for third party controls .
The global IVD quality control market is segmented on the basis of region into North America , Europe , Asia-Pacific , and LAMEA regions . North America dominated the global market in 2015 due to stringent mandates on the use of third party IVD quality control products by regulatory authorities . The Asia-Pacific and LAMEA regions are expected to provide lucrative opportunities to market players in the near future . Asia-Pacific is expected
2